Craft

Wuhan EasyDiagnosis Biomedicine

Stock Price

¥18.6

2024-10-29

Market Capitalization

¥4.2 B

2024-10-29

Revenue

¥243.9 M

FY, 2025

Wuhan EasyDiagnosis Biomedicine Summary

Company Summary

Overview
Wuhan EasyDiagnosis Biomedicine (武汉明德生物科技股份有限公司) is a manufacturer of in-vitro diagnostics reagents and auxiliary equipment. It offers automatic nucleic acid extraction and purification instruments, sample release reagents, blood gas testing cartridges, antigen test kits, and other products.
Type
Public
Status
Active
Founded
2008
Website
http://www.mdeasydiagnosis.com
Cybersecurity rating
Sectors

Table of Contents

Wuhan EasyDiagnosis Biomedicine Financials

Summary Financials

Revenue (Q1, 2026)
¥69.5M
Gross profit (Q1, 2026)
¥34.4M
Net income (Q1, 2026)
¥1.8M
Cash (Q1, 2026)
¥776.8M
EBIT (Q1, 2026)
(¥11.4M)
Enterprise value
$3.5B

Footer menu